Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and Emerging Treatments for Inflammatory Bowel Disease
Masaaki Higashiyama, Ryota Hokari
Digestion (2022) Vol. 104, Iss. 1, pp. 74-81
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis
Antonietta Gerarda Gravina, Raffaele Pellegrino, Marina Cipullo, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 1, pp. 17-33
Open Access | Times Cited: 27
The mysterious anelloviruses: investigating its role in human diseases
Mohammad Sabbaghian, Hamidreza Gheitasi, Ali Akbar Shekarchi, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel, et al.
Cureus (2023)
Open Access | Times Cited: 26
Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
Tsvetelina Velikova, Metodija Sekulovski, Monika Peshevska-Sekulovska
Antibodies (2024) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 10
Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease
Rocío Rivera Rodríguez, Jeremy J. Johnson
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108456-108456
Open Access | Times Cited: 19
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview
Sílvio André Lopes, Cesar Augusto Roque‐Borda, Jonatas Lobato Duarte, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2600-2600
Open Access | Times Cited: 19
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Novel Small Molecules in IBD: Current State and Future Perspectives
André Jefremow, Markus F. Neurath
Cells (2023) Vol. 12, Iss. 13, pp. 1730-1730
Open Access | Times Cited: 15
Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast
Chengjun Li, Yikai Wang, Shun-Ming Zhang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 42, pp. 5751-5767
Open Access | Times Cited: 13
Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future
Manish Manrai, Atul Jha, Saurabh Dawra, et al.
Future Pharmacology (2024) Vol. 4, Iss. 1, pp. 279-316
Open Access | Times Cited: 5
An overview on the cellular mechanisms of anthocyanins in maintaining intestinal integrity and function
Antonio Speciale, Maria Sofia Molonia, Claudia Muscarà, et al.
Fitoterapia (2024) Vol. 175, pp. 105953-105953
Open Access | Times Cited: 5
Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage Polarization
Alexandra Olate‐Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1616-1616
Open Access | Times Cited: 5
Hirschsprung’s disease may increase the incidence of inflammatory bowel disease through alterations in CA1
Enyang He, Bowen Shi, Miao Jia, et al.
Pediatric Research (2025)
Closed Access
The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease
Wenqian Wang, Wenfu Cao, Shenyun Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1996-1996
Open Access
Network pharmacology analysis and animal experiment validation of inflammation inhibition by Swertiamarin in treating Ulcerative colitis
Tang Jiafeng, Lijuan Wang, Lan Wei, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Dual-targeted Therapy for the Management of Refractory Crohn’s Disease: A Retrospective Cohort Study
Jindan He, Jiaqi Zhang, He Zhou, et al.
Research Square (Research Square) (2025)
Closed Access
Exploring the Impact of Cyanidin-3-Glucoside on Inflammatory Bowel Diseases: Investigating New Mechanisms for Emerging Interventions
Maximos Frountzas, Eva Karanikki, Orsalia Toutouza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9399-9399
Open Access | Times Cited: 12
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus
Massimo Claudio Fantini, Gionata Fiorino, Agostino Colli, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 8, pp. 1222-1231
Open Access | Times Cited: 4
Compound prebiotics as prophylactic and adjunctive treatments ameliorate DSS-induced colitis through gut microbiota modulation effects
Siyu Zhou, Hongxia Zhou, Qian Jia, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132362-132362
Closed Access | Times Cited: 4
Cucurbitacin IIa Alleviates Colitis via Promoting the Release of Host-Derived Extracellular Vesicles Encapsulating microRNA-30b-5p
Yinyin Zhao, Binyuan Jiang, Shengnan Zuo
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1447-1458
Open Access
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
Shiyi Wang, Xiaojian Wang, Jing Ding, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Type I Arabinogalactan and Methyl-Esterified Homogalacturonan Polysaccharides from Tamarillo (Solanum betaceum cav.) Fruit Pulp Ameliorate DSS-Induced Ulcerative Colitis
Lara Luisa Valerio de Mello Braga, Carolina Silva Schiebel, Gisele Simão, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 461-461
Open Access
Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease
Zonghui Ma, Steven McAninch, Zhiqing Liu, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 4, pp. 1152-1167
Closed Access
Alginate-pectin microparticles embedding self-assembling antimicrobial peptides and resveratrol for antimicrobial and anti-inflammatory applications
Cesar Augusto Roque‐Borda, Marco Roberto Chávez-Morán, Laura Maria Duran Gleriani Primo, et al.
Food Hydrocolloids (2025), pp. 111454-111454
Open Access
Disease Clearance in Ulcerative Colitis: A Narrative Review
Silvio Danese, Laurent Peyrin‐Biroulet, Vipul Jairath, et al.
United European Gastroenterology Journal (2025)
Open Access
Page 1 - Next Page

Scroll to top